Phio Pharma Shares Are Moving Higher On INTASYL Preclinical Data At ESMO PresentationBenzinga • 09/16/21
Phio Pharmaceuticals Presents Data at ESMO 2021 Demonstrating Persistent Anti-Tumor Immunity with INTASYL Dual-Targeting PD-1 and BRD4PRNewsWire • 09/16/21
Phio Pharmaceuticals to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference September 13th-15thPRNewsWire • 09/03/21
Phio Pharmaceuticals Announces Upcoming Data Presentation at the ESMO Virtual Congress 2021PRNewsWire • 08/31/21
Phio Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Business UpdatePRNewsWire • 08/12/21
Phio Pharmaceuticals Scheduled to Participate in a Fireside Chat with H.C. Wainwright on July 12thPRNewsWire • 07/07/21
Phio Pharmaceuticals Reschedules Fireside Chat Hosted by H.C. Wainwright for July 12thPRNewsWire • 06/22/21
Phio Pharmaceuticals Scheduled to Participate in Two Upcoming Investor Events in JunePRNewsWire • 06/14/21
Phio Pharmaceuticals Presents New In Vivo Data at the 2021 ASCO Annual Meeting Showing Dual-Targeting INTASYL Offers Increased Efficacy and Safety Potential Over Other Therapeutic ApproachesPRNewsWire • 06/04/21
Phio Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Business UpdatePRNewsWire • 05/13/21
Phio Pharmaceuticals Presents Positive In Vivo Data at ASGCT Showing PH-762 Significantly Enhanced Antitumor Efficacy of HER2-Targeted CAR-T CellsPRNewsWire • 05/11/21
Phio Pharmaceuticals Announces Upcoming Data Presentations at the ASGCT and ASCO Annual MeetingsPRNewsWire • 04/29/21
Phio Pharma's Intasyl Platform Shows Promising Tumor Control Activity In Animal StudiesBenzinga • 04/12/21
Phio Pharmaceuticals Presents Positive In Vivo Data Showing Strong Tumor Control for the Intratumoral Delivery of INTASYL™ RNAi Targeting PD-1PRNewsWire • 04/10/21
Phio Pharmaceuticals Reports 2020 Year End Financial Results and Provides Business UpdatePRNewsWire • 03/25/21
Phio Pharmaceuticals To Present New Data on PD-1 Targeting INTASYL at the 2021 American Association for Cancer Research (AACR) Annual MeetingPRNewsWire • 03/11/21
Phio Pharmaceuticals to Participate in the H.C. Wainwright Global Life Sciences Conference on March 9th-10thPRNewsWire • 02/23/21
Phio Pharmaceuticals Announces Closing of $7.7 Million Registered Direct Offering of Common Stock Priced At-the-MarketPRNewsWire • 02/17/21
Phio Pharmaceuticals Announces Closing of $14.0 Million Private Placement Priced At-the-MarketPRNewsWire • 01/25/21
Phio Pharmaceuticals Announces $14.0 Million Private Placement Priced At-the-MarketPRNewsWire • 01/21/21
Phio Pharmaceuticals to Participate in the H.C. Wainwright BioConnect 2021 ConferencePRNewsWire • 01/04/21
